Tag Archives: CMS
How Will Accountable Care Organizations Hit Drug Sales?
It’s not yet clear whether physicians will rush to form accountable care organizations (ACOs) in light of newly proposed Centers for Medicare and Medicaid Services (CMS) guidelines, which are lengthy, but pharmaceutical companies hoping to do business with ACOs will have to show that expensive brand drugs can offer not just better health outcomes, but [...]
Posted in Legal, News, Regulatory, Sales, Strategy, healthcare | Also tagged Affordable Care Act, healthcare reform, Medicare, physicians, Regulatory Guidelines | Leave a comment

Another Big Run on Pharma's Bank Account